This executive summary examines how consumer demand for mobility and active aging is reshaping the joint health supplement category, and how MyCondro™, a fermentation-derived, non-animal chondroitin sulfate, addresses challenges with raw material variability, traceability, and sustainability. It reviews the role of chondroitin sulfate in cartilage biology, pharmacokinetic data showing greater plasma concentration than animal-derived chondroitin, and two randomized, placebo-controlled trials conducted at 600 mg daily. It also outlines practical formulation and brand positioning considerations for product developers.
The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.
BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.
As GLP-1 medications and social media reshape how patients hear about nutrition, closing the gap between emerging science and everyday clinical care depends on stronger, more practical continuing education for healthcare providers.